Position in VTRS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$26,224,017
+$1,457,432 QoQ
Shares Held
1,941,082
-2.4% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 71.10982431448028.ToString("F0")%
Shared 0.ToString("F0")%
None 28.890175685519726.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,229,009 | $145,281,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
122,486 | $72,631,748 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
303,820 | $40,025,246 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,268,203 | $30,348,097 | |
| 5 | VTRS |
Viatris Inc
This page
|
1,941,082 | $26,224,017 | |
| 6 | ALKS |
Alkermes plc.
|
449,531 | $15,895,416 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
194,563 | $14,757,603 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
643,856 | $13,366,450 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,224,017 | 1,941,082 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $24,766,585 | 1,989,284 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,816,541 | 2,102,681 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $18,923,732 | 2,119,119 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $28,213,728 | 3,239,234 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $35,696,938 | 2,867,224 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $31,890,127 | 2,746,781 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,257,540 | 2,093,842 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $25,132,506 | 2,104,900 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $22,876,230 | 2,112,302 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $21,205,399 | 2,150,649 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $21,923,275 | 2,196,721 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $21,649,309 | 2,250,448 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $24,422,904 | 2,194,331 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $18,197,731 | 2,135,884 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $21,306,334 | 2,034,989 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $19,648,431 | 1,805,922 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $22,945,824 | 1,695,922 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $22,729,271 | 1,677,437 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $24,853,410 | 1,739,217 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $25,081,263 | 1,795,366 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $35,567,189 | 1,897,929 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||